Threshold Ledger · Independent DeskIbogaine & MethadoneHarm reduction · Evidence over hype
Independent · Evidence-led · Plain languageThreshold Ledger
Clear reporting on ibogaine–methadone decisions
The core danger

Ibogaine + Methadone: Cardiac & QT Risk

The reason this combination is treated with such caution is the heart. Both drugs can lengthen the QT interval; together, they can push it into dangerous territory.

Methadone is well known to prolong the QT interval; ibogaine does too. Prolong it far enough and the heart becomes vulnerable to torsades de pointes, a potentially fatal rhythm. That shared mechanism is the core reason ibogaine and methadone are not given together.

The mechanism

What “QT prolongation” means

The QT interval reflects how long the heart’s ventricles take to reset between beats. Drugs that lengthen it — including methadone and ibogaine — leave a wider window in which a mistimed beat can trigger a chaotic rhythm. Dehydration, low potassium or magnesium, and other QT-prolonging medications all stack the risk higher.

Fig. 1 — The interval both drugs stretchIllustrative ECG
QT INTERVALIbogaine and methadone can each lengthen this window — together, the effect compounds.
Two QT-prolonging drugs at once is the scenario responsible protocols are built to avoid.
Beyond the heart

Respiratory depression, too

There is a second hazard: if ibogaine is introduced while methadone levels remain high, the central nervous system can be sensitised to respiratory depression. This is why residual opioid load — not just the calendar — determines readiness, and why a washout is verified rather than assumed.

Guarding against it

What proper screening and monitoring cover

Responsible programs require a baseline ECG with QT measurement, electrolyte panels, and a full medication review before anything proceeds; during and after dosing they monitor blood pressure, heart rate and rhythm continuously, with emergency readiness on hand. People with structural heart disease, a long baseline QT, or on other QT-prolonging drugs may be excluded outright.

More from the Ledger

Keep reading